5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft-Reference-Cited by-同舟云学术

5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft

Published:2013-09-16 Issue:10 Volume:4 Page:1737-1747
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Borodovsky Alexandra¹,Salmasi Vafi¹,Turcan Sevin²,Fabius Armida W. M.²,Baia Gilson S.¹,Eberhart Charles G.³,Weingart Jon D.¹⁴,Gallia Gary L.¹⁴,Baylin Stephen B.⁴,Chan Timothy A.²,Riggins Gregory J.¹⁴

Affiliation:

1. Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA

2. Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

3. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

4. Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting DNA Methylation Machinery in Pediatric Solid Tumors;Cells;2024-07-18

2. Favorable Radiographic Response in a Patient With an Oligodendroglioma Treated With Azacitidine and Venetoclax for Acute Myeloid Leukemia;Cureus;2024-06-02

3. Alteration in DNA methylation patterns: Epigenetic signatures in gastrointestinal cancers;European Journal of Pharmacology;2024-06

4. Optimization of Epigenetic Modifier Drug Combination for Synergistic Effect against Glioblastoma Multiform Cancer Cell Lines;Cancer Investigation;2024-04-20

5. IDH mutation, glioma immunogenicity, and therapeutic challenge of primary mismatch repair deficient IDH‐mutant astrocytoma PMMRDIA: a systematic review;Molecular Oncology;2024-02-09